- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Pharmacokinetics of Inhaled Antimicrobials
Authors
Keywords
Cystic Fibrosis, Respiratory Syncytial Virus, Colistin, Zanamivir, Pentamidine
Journal
CLINICAL PHARMACOKINETICS
Volume 54, Issue 5, Pages 473-492
Publisher
Springer Nature
Online
2015-03-03
DOI
10.1007/s40262-015-0250-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improving the efficacy of inhaled drugs in cystic fibrosis: Challenges and emerging drug delivery strategies
- (2014) Ivana d'Angelo et al. ADVANCED DRUG DELIVERY REVIEWS
- Emerging inhalation aerosol devices and strategies: Where are we headed?
- (2014) Qi (Tony) Zhou et al. ADVANCED DRUG DELIVERY REVIEWS
- Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications
- (2014) Chris Stockmann et al. CLINICAL PHARMACOKINETICS
- A Randomized Double-Blind Placebo-Controlled Dose-Escalation Phase 1 Study of Aerosolized Amikacin and Fosfomycin Delivered via the PARI Investigational eFlow® Inline Nebulizer System in Mechanically Ventilated Patients
- (2014) A. Bruce Montgomery et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- High tobramycin serum concentrations after tobramycin inhalation in a child with renal failure
- (2014) F. de Velde et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of two tobramycin nebuliser solutions: Pharmacokinetic, efficacy and safety profiles of T100 and TNS
- (2014) Dorota Sands et al. Journal of Cystic Fibrosis
- DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation
- (2014) S. Chalkias et al. Transplant Infectious Disease
- Levofloxacin inhalation solution for the treatment of chronicPseudomonas aeruginosainfection among patients with cystic fibrosis
- (2014) Chris Stockmann et al. Expert Review of Respiratory Medicine
- Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children
- (2014) Alpana Waghmare et al. Journal of the Pediatric Infectious Diseases Society
- Synergistic Antibiotic Combination Powders of Colistin and Rifampicin Provide High Aerosolization Efficiency and Moisture Protection
- (2013) Qi Zhou et al. AAPS Journal
- Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
- (2013) Heino Stass et al. CLINICAL DRUG INVESTIGATION
- Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study
- (2013) Heino Stass et al. CLINICAL THERAPEUTICS
- Population Pharmacokinetics of Laninamivir and Its Prodrug Laninamivir Octanoate in Healthy Subjects and in Adult and Pediatric Patients with Influenza Virus Infection
- (2013) Kazutaka Yoshihara et al. Drug Metabolism and Pharmacokinetics
- Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a Phase II randomized study
- (2013) Sabina Antoniu et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis
- (2013) Gabrielle Pilcer et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A Pharmacokinetics and Safety Comparison of a Highly Concentrated Tobramycin Solution with TOBI
- (2013) Matthias Griese et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Encapsulation into PEG-Liposomes Does Not Improve the Bioavailability of Pulmonary Delivered Salmon Calcitonin
- (2013) Janani Swaminathan et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection
- (2013) J P Clancy et al. THORAX
- Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
- (2013) David J Serisier et al. THORAX
- Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis
- (2013) Chris Stockmann et al. Therapeutic Advances in Respiratory Disease
- Intrapulmonary Distribution and Pharmacokinetics of Laninamivir, a Neuraminidase Inhibitor, after a Single Inhaled Administration of Its Prodrug, Laninamivir Octanoate, in Healthy Volunteers
- (2012) Hitoshi Ishizuka et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
- (2012) Robert Wilson et al. EUROPEAN RESPIRATORY JOURNAL
- Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients
- (2012) Zoe E. Athanassa et al. INTENSIVE CARE MEDICINE
- Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones
- (2012) Chris Stockmann et al. PEDIATRIC PULMONOLOGY
- Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems
- (2012) Jeffery T. Zobell et al. PEDIATRIC PULMONOLOGY
- Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow® rapid and PARI LC Plus® nebulisers in cystic fibrosis patients
- (2012) Mirco Govoni et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient
- (2012) D.R. Drozd et al. Transplant Infectious Disease
- Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis withPseudomonas aeruginosa
- (2011) David E. Geller et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetics and Safety of MP-376 (Levofloxacin Inhalation Solution) in Cystic Fibrosis Subjects
- (2011) David E. Geller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of inhaled cidofovir as postexposure prophylactic in an aerosol rabbitpox model
- (2011) Daniel Verreault et al. ANTIVIRAL RESEARCH
- BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia
- (2011) Michael S. Niederman et al. INTENSIVE CARE MEDICINE
- Pharmacokinetics and Tolerability of BAY41-6551 in Subjects with Chronic Kidney Disease
- (2011) Heino Stass et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
- (2011) David E. Geller et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa
- (2011) C.E. Wainwright et al. Journal of Cystic Fibrosis
- Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition
- (2011) Christopher J. Vavricka et al. PLoS Pathogens
- Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity after a Single Administration
- (2010) S. Kubo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Long‐Acting Neuraminidase Inhibitor Laninamivir Octanoate versus Oseltamivir for Treatment of Influenza: A Double‐Blind, Randomized, Noninferiority Clinical Trial
- (2010) Akira Watanabe et al. CLINICAL INFECTIOUS DISEASES
- Aztreonam Lysine for Inhalation Solution
- (2010) Greg L. Plosker DRUGS
- Clinical Pharmacokinetics of Laninamivir, a Novel Long-Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS-8958, in Healthy Male Volunteers
- (2010) Hitoshi Ishizuka et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Assessment of the Effects of Renal Impairment on the Pharmacokinetic Profile of Laninamivir, a Novel Neuraminidase Inhibitor, After a Single Inhaled Dose of Its Prodrug, CS-8958
- (2010) Hitoshi Ishizuka et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects
- (2010) Warren Lenney et al. Journal of Cystic Fibrosis
- Aerosol drug delivery: developments in device design and clinical use
- (2010) Myrna B Dolovich et al. LANCET
- An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis
- (2010) Christopher M. Oermann et al. PEDIATRIC PULMONOLOGY
- Optimization of freeze-drying condition of amikacin solid lipid nanoparticles using D-optimal experimental design
- (2010) Jaleh Varshosaz et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Intrapulmonary Disposition of Amphotericin B After Aerosolized Delivery of Amphotericin B Lipid Complex (Abelcet; ABLC) in Lung Transplant Recipients
- (2010) Shahid Husain et al. TRANSPLANTATION
- Agglomerates of Ciprofloxacin Nanoparticles Yield Fine Dry Powder Aerosols
- (2010) Nashwa El-Gendy et al. Journal of Pharmaceutical Innovation
- Initial Characterization of Micafungin Pulmonary Delivery via Two Different Nebulizers and Multivariate Data Analysis of Aerosol Mass Distribution Profiles
- (2009) Shuai Shi et al. AAPS PHARMSCITECH
- Inhaled Voriconazole for Prevention of Invasive Pulmonary Aspergillosis
- (2009) J. A. Tolman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection
- (2009) O. O. Okusanya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CS-8958, a Prodrug of the Novel Neuraminidase Inhibitor R-125489, Demonstrates a Favorable Long-Retention Profile in the Mouse Respiratory Tract
- (2009) K. Koyama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
- (2009) George Z. Retsch-Bogart et al. CHEST
- Therapeutic Effect of Recombinant Human Catalase on H1N1 Influenza-induced Pneumonia in Mice
- (2009) Xun-long Shi et al. INFLAMMATION
- Pharmacokinetics and safety of tobramycin administered by the PARI eFlow® rapid nebulizer in cystic fibrosis
- (2009) Dominique Hubert et al. Journal of Cystic Fibrosis
- Pharmacokinetics and antibacterial activity of inhaled liposomal ciprofloxacin hydrochloride in healthy volunteers and in cystic fibrosis (CF) patients
- (2009) P. Bruinenberg et al. Journal of Cystic Fibrosis
- Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety
- (2009) Víctor Monforte et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Use of Colistin in Children
- (2009) Pranita D. Tamma et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Aerosolized vancomycin for the treatment of MRSA after lung transplantation
- (2009) Don HAYES JR et al. RESPIROLOGY
- A Comparision of Several Formats of Amphotericin B as an Inhaled Antifungal Prophylaxis
- (2009) E. SanMartín et al. TRANSPLANTATION PROCEEDINGS
- Microparticles for Inhalational Delivery of Antipseudomonal Antibiotics
- (2008) Michael D. Tsifansky et al. AAPS Journal
- Inhaled Aztreonam Lysine for Chronic AirwayPseudomonas aeruginosain Cystic Fibrosis
- (2008) Karen S. McCoy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity
- (2008) M. Yamashita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MegaRibavirin aerosol for the treatment of influenza A virus infections in mice
- (2008) Brian E. Gilbert et al. ANTIVIRAL RESEARCH
- Developing New Antiviral Agents for Influenza Treatment: What Does the Future Hold?
- (2008) Frederick Hayden CLINICAL INFECTIOUS DISEASES
- High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers
- (2008) Wei Yang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery
- (2008) G PILCER et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections
- (2008) P. Meers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The science of aerosol delivery in cystic fibrosis
- (2008) David E. Geller PEDIATRIC PULMONOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started